Displaying drugs 14451 - 14475 of 15216 in total
Indole-3-carbinol
Indole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).
Investigational
Iopydol
Experimental
Obidoxime
Experimental
2-Amino-3-(1h-Indol-3-Yl)-Propan-1-Ol
Experimental
4-O-Demethylpenclomedine
Investigational
2-heptyl-4-hydroxyquinoline N-oxide
Experimental
(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE
Experimental
Thiacloprid
Experimental
Iprindole
Experimental
Tretoquinol
Experimental
AZD2066
Investigational
4-(1H-IMIDAZOL-1-YL)PHENOL
Experimental
Motexafin lutetium
Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer. It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. Motexafin lutetium is a pentadentate aromatic metallotexaphyrin with photosensitizing properties.
Investigational
ZK-805623
Experimental
Displaying drugs 14451 - 14475 of 15216 in total